Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Tonix Pharmaceuticals Holding Corp (TNXP)

  • Event
  • July 29, 2022, 21:01 UTC
  • 14
  • 1 comments

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Reports Q3 2022 Financial Results

Comment Full text

Shattuck Labs Inc (STTK)

  • Event
  • July 29, 2022, 20:26 UTC
  • 14
  • 1 comments

(99% Neutral) Shattuck Labs, Inc. (STTK) Announces Business Combination

Comment Full text

Summit Plc (SMMT)

  • Event
  • July 29, 2022, 16:08 UTC
  • 14
  • 1 comments

(99% Neutral) Summit Therapeutics Inc. (SMMT) Files Form 8-K

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • July 29, 2022, 13:17 UTC
  • 95
  • 0 comments

Quantum-Si - Quantum-Si at the UBS Genomics 2.0 and MedTech Innovations Summit

Comment Full text

QuantumSi Inc (QSI)

  • Event
  • July 29, 2022, 13:17 UTC
  • 96
  • 0 comments

Quantum-Si - Quantum-Si at the at the Canaccord Genuity 42nd Annual Growth Conference

Comment Full text

TherapeuticsMD Inc (TXMD)

  • Event
  • July 29, 2022, 12:58 UTC
  • 14
  • 1 comments

(99% Neutral) TherapeuticsMD, Inc. (TXMD) Announces Clinical Development Update

Comment Full text

Passage Bio Inc. (PASG)

  • Event
  • July 29, 2022, 12:55 UTC
  • 92
  • 0 comments

Passage Bio, Inc. - Passage Bio Reports Second Quarter 2022 Financial Results and Recent Business Highlights

Comment Full text

AstraZeneca (AZN)

  • Event
  • July 29, 2022, 11:59 UTC
  • 11
  • 1 comments

(10% Negative) AstraZeneca (AZN) Files Form 6-K

Comment Full text

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • July 29, 2022, 11:06 UTC
  • 11
  • 1 comments

(99% Neutral) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Clinical Development Update (Form 6-K)

Comment Full text

ImmunoGen Inc (was acquired by AbbVie (NYSE: ABBV) on 12/02/2024) (IMGN)

  • Event
  • July 29, 2022, 10:41 UTC
  • 14
  • 1 comments

(30% Negative) ImmunoGen, Inc. (IMGN) Reports Q3 2022 Financial Results

Comment Full text
  • Previous
  • 147
  • 148
  • 149
  • 150
  • 151
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2261)
  • SEC News(189437)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124580)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin